CEMEX SAB-SPONS ADR PART CER (CX)

US1512908898 - ADR

8.11  -0.16 (-1.93%)

After market: 8.11 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CX. CX was compared to 12 industry peers in the Construction Materials industry. CX has a bad profitability rating. Also its financial health evaluation is rather negative. CX is valued quite cheap, while showing a decent growth score. This is a good combination!



3

1. Profitability

1.1 Basic Checks

In the past year CX was profitable.
In the past year CX had a positive cash flow from operations.
CX had positive earnings in 4 of the past 5 years.
CX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.64%, CX is doing worse than 83.33% of the companies in the same industry.
With a Return On Equity value of 1.54%, CX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 6.75%, CX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CX had an Average Return On Invested Capital over the past 3 years of 6.67%. This is below the industry average of 10.43%.
The last Return On Invested Capital (6.75%) for CX is above the 3 year average (6.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.64%
ROE 1.54%
ROIC 6.75%
ROA(3y)2.24%
ROA(5y)0.37%
ROE(3y)5.79%
ROE(5y)0.15%
ROIC(3y)6.67%
ROIC(5y)5.81%

1.3 Margins

CX has a worse Profit Margin (1.05%) than 75.00% of its industry peers.
In the last couple of years the Profit Margin of CX has declined.
CX has a worse Operating Margin (10.62%) than 66.67% of its industry peers.
CX's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 33.65%, CX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
CX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.62%
PM (TTM) 1.05%
GM 33.65%
OM growth 3Y6%
OM growth 5Y-0.54%
PM growth 3YN/A
PM growth 5Y-23.14%
GM growth 3Y1.57%
GM growth 5Y-0.52%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CX is destroying value.
CX has about the same amout of shares outstanding than it did 1 year ago.
CX has less shares outstanding than it did 5 years ago.
CX has a better debt/assets ratio than last year.

2.2 Solvency

CX has an Altman-Z score of 1.40. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
CX's Altman-Z score of 1.40 is on the low side compared to the rest of the industry. CX is outperformed by 75.00% of its industry peers.
The Debt to FCF ratio of CX is 7.61, which is on the high side as it means it would take CX, 7.61 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.61, CX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.61 indicates that CX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.61, CX is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 7.61
Altman-Z 1.4
ROIC/WACC0.53
WACC12.68%

2.3 Liquidity

CX has a Current Ratio of 0.74. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CX (0.74) is worse than 83.33% of its industry peers.
A Quick Ratio of 0.47 indicates that CX may have some problems paying its short term obligations.
CX's Quick ratio of 0.47 is on the low side compared to the rest of the industry. CX is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.47

4

3. Growth

3.1 Past

CX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.70%.
CX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.04% yearly.
Looking at the last year, CX shows a decrease in Revenue. The Revenue has decreased by -9.98% in the last year.
The Revenue has been growing slightly by 5.14% on average over the past years.
EPS 1Y (TTM)2.7%
EPS 3YN/A
EPS 5Y-16.04%
EPS growth Q2Q0.2%
Revenue 1Y (TTM)-9.98%
Revenue growth 3Y10.71%
Revenue growth 5Y5.14%
Revenue growth Q2Q9.69%

3.2 Future

The Earnings Per Share is expected to grow by 75.61% on average over the next years. This is a very strong growth
Based on estimates for the next years, CX will show a small growth in Revenue. The Revenue will grow by 3.25% on average per year.
EPS Next Y170.77%
EPS Next 2Y120.77%
EPS Next 3Y75.61%
EPS Next 5YN/A
Revenue Next Year6.85%
Revenue Next 2Y5.39%
Revenue Next 3Y4.67%
Revenue Next 5Y3.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.23 indicates a correct valuation of CX.
91.67% of the companies in the same industry are more expensive than CX, based on the Price/Earnings ratio.
CX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.84.
With a Price/Forward Earnings ratio of 5.25, the valuation of CX can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CX indicates a rather cheap valuation: CX is cheaper than 100.00% of the companies listed in the same industry.
CX is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.23
Fwd PE 5.25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.94
EV/EBITDA 5.99

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CX's earnings are expected to grow with 75.61% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y120.77%
EPS Next 3Y75.61%

5

5. Dividend

5.1 Amount

CX has a Yearly Dividend Yield of 12.00%, which is a nice return.
CX's Dividend Yield is rather good when compared to the industry average which is at 2.53. CX pays more dividend than 100.00% of the companies in the same industry.
CX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 12%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CX pays out 65.87% of its income as dividend. This is not a sustainable payout ratio.
DP65.87%
EPS Next 2Y120.77%
EPS Next 3Y75.61%

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (4/29/2024, 3:15:00 PM)

After market: 8.11 0 (0%)

8.11

-0.16 (-1.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.75B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 12%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.23
Fwd PE 5.25
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 1.54%
ROCE
ROIC
ROICexc
ROICexgc
OM 10.62%
PM (TTM) 1.05%
GM 33.65%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.74
Quick Ratio 0.47
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)2.7%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y170.77%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-9.98%
Revenue growth 3Y10.71%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y